Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Unknown 1Terminated 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2Breast 1

Conditions

Colonic Neoplasms 7Colorectal Neoplasms 6Rectal Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Breast Neoplasms 3Liver Neoplasms 2Head and Neck Neoplasms 2Hand-Foot Syndrome 2Adenomatous Polyposis Coli 2Smoking 1Pancreatic Neoplasms 1Pain, Postoperative 1Pain 1Nasopharyngeal Carcinoma 1Lymphoma, Follicular 1Lung Neoplasms 1Influenza, Human 1Drug-Related Side Effects and Adverse Reactions 1Breast Neoplasms, Male 1Agnosia 1Adenocarcinoma of Lung 1

Interventions

Pyridoxine 2Celecoxib 2Capecitabine 2tegafur-gimeracil-oteracil 1mecobalamin 1S 1 (combination) 1Radiotherapy 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Hand-Foot Syndrome × Celecoxib × Clear all
NCT05327751 2022-04-14

HFS

Tanta University

Phase 3 Unknown
44 enrolled
Gastrointestinal

Colorectal Neoplasms, Hand-Foot Syndrome

NCT00305643 2015-12-24

Celecoxib in Preventing Hand/Foot Syndrome Caused By Capecitabine With Metastatic Breast or Colorectal Cancer

M.D. Anderson Cancer Center

Phase 3 Terminated
11 enrolled 7 charts
BreastGastrointestinal

Breast Neoplasms, Colonic Neoplasms, Pain, Rectal Neoplasms, Colorectal Neoplasms, Breast Neoplasms, Male, Hand-Foot Syndrome, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡